Current Value of Holding

$852 Million

Shares

22.1 Million

% of Portfolio

2.54%

Average Buy Price

$27.6

Avg closing price
Price range

3 Andreas Halvorsen BridgeBio Pharma Trades

Andreas Halvorsen's position in BridgeBio Pharma is currently worth $852 Million. That's 2.54% of their equity portfolio (14th largest holding). The investor owns 13.10% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 4.57 Million shares. The stake costed the investor $608 Million, netting the investor a gain of 40% so far.

Avg closing price
Price range
Sold 12.2% shares (-3.07 Million shares) Jan 31, 2025
Avg closing price $34.21
Price range $34.21 - $34.21
Sold 5.6% shares (-1.5 Million shares) Jul 18, 2023
Avg closing price $32.52
Price range $32.52 - $32.52
New holding (+26.6 Million shares) Jun 27, 2019
Avg closing price $27.55
Price range $27.55 - $27.55

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!